nektar therapeutics (NKTR:NASDAQ GS)
Robert B. Chess
|Age||Total Calculated Compensation||This person is connected to 139 board members in 6 different organizations across 6 different industries.|
See Board Relationships
Mr. Robert B. Chess, also known as Rob, served as the Chief Executive Officer of OPX Biotechnologies, Inc. Mr. Chess served as the President and Chief Executive Officer of Nektar Therapeutics from March 17, 2006 to January 15, 2007 and served as its Interim President and Acting Chief Executive Officer from March 17, 2006 to January 15, 2007. Mr. Chess served as an Interim President and Chief Executive Officer of Nektar Therapeutics, from 1992 to 2000. He served as Co-Chief ...
455 Mission Bay Boulevard SouthPhone: 415-482-5300
San Francisco, California 94158
Board Members Memberships*
Independent Director and Member of Nominating & Corporate Governance Committee
Harvard Business School
California Institute of Technology
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|Peter S. Greenleaf||Chief Executive Officer and Director|
Sucampo Pharmaceuticals, Inc.
|Richard Martin Steeves Ph.D.||Group Chief Executive Officer, Member of Senior Executive Board and Executive Director|
Synergy Health plc
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee|
Emergent BioSolutions, Inc.
|$1.2M||Compensation as of Fiscal Year 2014.|